The 150-year-old drugmaker is the first company in health care to hit the milestone.
Category: Insulin
-
Trump Seeks to Lower Drug Prices Through Medicare and Some Imports
President Trump directed his administration to help states import drugs from Canada. But a proposal to alter a Medicare program to reduce costs could wind up raising prices.
-
Insulin Prices Dropped. But Some Poor Patients Are Paying More.
A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for low-income health clinics.
-
On Drug Prices, Harris Pushes for Deeper Cuts While Trump Offers Few Specifics
Both have campaigned for lower prescription costs. Kamala Harris has promised to expand President Biden’s policies. Donald Trump is a wild card.
-
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.
-
Hot Summer Threatens Efficacy of Mail-Order Medications
The temperatures inside delivery trucks can reach twice the recommended threshold, but federal rules on drug storage conditions do not apply to the booming world of mail-order delivery.
-
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy
Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss drugs, but the Danish company has far bigger ambitions.
-
Your Inhalers and EpiPens Aren’t Very Healthy for the Environment
For eco-conscious consumers of personal medical devices, recycling options are limited. Some companies are trying to change that.
-
Your Inhalers and EpiPens Aren’t Very Healthy for the Environment
For eco-conscious consumers of personal medical devices, recycling options are limited. Some companies are trying to change that.
-
California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts
The New York Times – Business:The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.
-
Sanofi Plans to Cut the Price of Insulin
The New York Times – Business:The company is the third of the three major insulin manufacturers that dominate the U.S. market to announce such a move this month.
-
Novo Nordisk Says It Will Slash the Price of Insulin
The New York Times – Business:The company’s decision follows a similar move by its rival, Eli Lilly, this month.